System Transmission

Top Signal

100#1 JOB

Activity

2162Ripe

+917 today

System

Live2m

Terminal Asset View

stockNASDAQ

APLS

$18.94+2.99%

Apellis Pharmaceuticals Inc

Neutral

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

43Neutral

Live Analysis Active

Synchronizing Data Stream

Establishing multi-vendor link for APLS

Pipeline Initializing...

System Progress0%

Low Latency Link

Encrypted Port

Company Mission

Apellis Pharmaceuticals develops and sells treatments for rare eye diseases like geographic atrophy. Their main product is a medication that helps slow vision loss in patients with this condition. The company makes money by selling these drugs to healthcare providers and patients through prescriptions.

APL

Industry Context

Apellis operates in the biotechnology sector, which focuses on developing treatments for rare diseases. This sector often experiences significant price swings as investors react to clinical trial results and regulatory decisions. Companies in this space typically have high research costs and depend on successful drug approvals for revenue.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

57Matrix

Market Momentum

33.0— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Accelerating

Velocity Score

Accelerating

StaticOptimal FlowMax Vel

Trading Activity

0.8x— Normal Volume

Today's Change

2.99%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing APLS across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 08:03 PM UTC

As-of 03-14-2026 19:47 UTC

Develops drugs that treat rare eye diseases and makes money by selling these treatments through hospitals and pharmacies.

Weekly chart shows range contraction, indicating a coiling pattern that often precedes breakouts when price movement tightens.

Biotech sector volatility remains elevated, suggesting investors should watch for sector rotation into healthcare during market uncertainty.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...